Finerenone and Cardiorenal Outcomes by History of Atherosclerotic Cardiovascular Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease: FIDELITY Analyses
Date:
October 3rd 2022, 2:46 pm EDT
Finerenone in Patients With CKD and T2D by SGLT-2i Treatment: The Fidelity Prespecified Pooled Analysis
October 3rd 2022, 3:15 pm EDT
